How to buy Bionano Genomics stock | $6.17

Bionano Genomics, Inc is a diagnostics & research business based in the US. Bionano Genomics shares (BNGO) are listed on the NASDAQ and all prices are listed in US Dollars. Bionano Genomics employs 147 staff and has a trailing 12-month revenue of around 0.00.

Bionano Genomics stock price (NASDAQ: BNGO)

Use our graph to track the performance of BNGO stocks over time.

Bionano Genomics shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$6.17
52-week range	$0.47 - $15.69
50-day moving average	$6.87
200-day moving average	$7.83
Wall St. target price	$11.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-2.76

Buy Bionano Genomics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Bionano Genomics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Bionano Genomics, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bionano Genomics price performance over time

Historical closes compared with the close of $6.17 from 2021-05-28

1 week (2021-07-23)	N/A
1 month (2021-07-02)	-8.18%
3 months (2021-05-03)	3.01%
6 months (2021-01-30)	N/A

1 year (2020-07-30)	N/A
2 years (2019-07-30)	N/A
3 years (2018-07-30)	N/A
5 years (2016-07-30)	N/A

Bionano Genomics financials

Revenue TTM	$10.5 million
Gross profit TTM	$2.8 million
Return on assets TTM	-11.9%
Return on equity TTM	-22.62%
Profit margin	0%
Book value	$1.30
Market capitalisation	$1.7 billion

TTM: trailing 12 months

Shorting Bionano Genomics shares

There are currently 44.9 million Bionano Genomics shares held short by investors – that's known as Bionano Genomics's "short interest". This figure is 13.8% down from 52.1 million last month.

There are a few different ways that this level of interest in shorting Bionano Genomics shares can be evaluated.

Bionano Genomics's "short interest ratio" (SIR)

Bionano Genomics's "short interest ratio" (SIR) is the quantity of Bionano Genomics shares currently shorted divided by the average quantity of Bionano Genomics shares traded daily (recently around 15.5 million). Bionano Genomics's SIR currently stands at 2.89. In other words for every 100,000 Bionano Genomics shares traded daily on the market, roughly 2890 shares are currently held short.

However Bionano Genomics's short interest can also be evaluated against the total number of Bionano Genomics shares, or, against the total number of tradable Bionano Genomics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bionano Genomics's short interest could be expressed as 0.16% of the outstanding shares (for every 100,000 Bionano Genomics shares in existence, roughly 160 shares are currently held short) or 0.1629% of the tradable shares (for every 100,000 tradable Bionano Genomics shares, roughly 163 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Bionano Genomics.

Find out more about how you can short Bionano Genomics stock.

Bionano Genomics share dividends

We're not expecting Bionano Genomics to pay a dividend over the next 12 months.

Bionano Genomics share price volatility

Over the last 12 months, Bionano Genomics's shares have ranged in value from as little as $0.4735 up to $15.69. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bionano Genomics's is 1.9894. This would suggest that Bionano Genomics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Bionano Genomics overview

Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes. Its Saphyr system includes an instrument, chip consumables, reagents, a suite of data analysis tools, and genome analysis services for researchers to evaluate optical genome mapping data. The company's Bionano prep kits and labeling kits provide the reagents and protocols needed to extract and label ultra-high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. The company was formerly known as BioNano Genomics, Inc.

Frequently asked questions

What percentage of Bionano Genomics is owned by insiders or institutions?
Currently 0.338% of Bionano Genomics shares are held by insiders and 16.869% by institutions. How many people work for Bionano Genomics?
Latest data suggests 147 work at Bionano Genomics. When does the fiscal year end for Bionano Genomics?
Bionano Genomics's fiscal year ends in December. Where is Bionano Genomics based?
Bionano Genomics's address is: 9540 Towne Centre Drive, San Diego, CA, United States, 92121 What is Bionano Genomics's ISIN number?
Bionano Genomics's international securities identification number is: US09075F1075 What is Bionano Genomics's CUSIP number?
Bionano Genomics's Committee on Uniform Securities Identification Procedures number is: 09075F107